Mark R. Olsen
Mark R. Olsen publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology and Lung Cancer Research Studies.
- World rank
- #2,109,655 of 7,710,434 ranked researchers
- Rank in United States
- #636,475 of 1,627,098
- Works
- 30
- Citations
- 1.2k
- Citations per work
- 39.5
What does Mark R. Olsen research?
Mark R. Olsen's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (26%), Chemistry (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1861.6%
- Medicine1861.6%
- Life Sciences825.6%
- Everything else39.3%
- Physical Sciences13.5%
- Chemistry13.5%
- 1Pulmonary and Respiratory Medicine31% of their works
- 2Oncology30% of their works
- 3Molecular Biology9% of their works
- 4Genetics9% of their works
- 5Cancer Research7% of their works
- 6Organic Chemistry4% of their works
Research topics
Which keywords describe Mark R. Olsen's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Immunotherapy, Prognostic Factors, ALK Inhibitors, EGFR Mutations and Chemotherapy-Induced Peripheral Neuropathy.
- Cetuximab
- CT Screening
- PD-1 and PD-L1
- Estrogen
- Small-Cell Lung Cancer
- Metastatic
- Chemotherapy-Induced Peripheral Neuropathy
- ALK Inhibitors
- Immunotherapy
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- Prognostic Factors
- EGFR Mutations
- Genomic Profiles
- Renal Cell Carcinoma
- Taxanes
- Immune Checkpoint Blockade
- Receptor
- Lung Cancer
- KRAS Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Clinical Trials162 topics
- Targeted Therapy162 topics
- Chemotherapy143 topics
- Immunotherapy142 topics
- Prognostic Factors142 topics
- ALK Inhibitors91 topic
- EGFR Mutations91 topic
- Chemotherapy-Induced Peripheral Neuropathy71 topic
- Genomic Profiles71 topic
- Metastatic71 topic
- Renal Cell Carcinoma71 topic
- Small-Cell Lung Cancer71 topic
- Taxanes71 topic
- Estrogen61 topic
- Immune Checkpoint Blockade61 topic
- PD-1 and PD-L161 topic
- Receptor61 topic
- CT Screening41 topic
- Lung Cancer41 topic
- Cetuximab31 topic
- KRAS Mutations31 topic
Where does Mark R. Olsen work?
Mark R. Olsen's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Mark R. Olsen have?
OpenAlex counts 30 works and 1,185 citations for Mark R. Olsen, an h-index of 13, ranking #2,109,655 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark R. Olsen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.